Glutathione and Acid Reflux: What Studies Report

Answer first: the direct evidence does not exist

Among the verified papers reviewed for this page, none studied glutathione in people with acid reflux, gastro-oesophageal reflux disease (GERD), reflux oesophagitis or Barrett's oesophagus. There were no randomised trials, no cohort studies and no case series using heartburn frequency, regurgitation scores, pH-metry, endoscopic healing or proton-pump-inhibitor sparing as endpoints. That absence is the most accurate summary available: the question "is glutathione good for acid reflux" has not been tested in a form that published human research can answer.

What does exist is a body of work on glutathione as a redox molecule — its chemistry, how it is measured, what happens when it is supplemented in healthy adults, and what happened in animals exposed to an oxidative challenge. Those studies are informative about glutathione biology and uninformative about reflux specifically. This page is for educational purposes only and is not medical advice; consult a licensed physician about symptoms such as heartburn, chest pain or difficulty swallowing.

What glutathione is in the published literature

Glutathione is a tripeptide of glutamate, cysteine and glycine that reviewers have described as the dominant low-molecular-weight thiol antioxidant inside cells, cycling between a reduced form (GSH) and an oxidised disulfide form (GSSG) and serving as a substrate for glutathione peroxidases and glutathione S-transferases (PMID 36707132). A separate review examined glutathione in the context of peroxisome redox homeostasis, describing compartment-specific pools and how glutathione status intersects with hydrogen peroxide handling inside organelles (PMID 37804696). A further review framed declining glutathione status as a proposed feature of biological ageing (PMID 39316535).

None of those reviews addressed lower-oesophageal sphincter function, gastric acid secretion, oesophageal mucosal integrity or reflux symptom scores. They describe a general antioxidant system, which is the reason glutathione appears in speculative discussions about many inflammatory or mucosal conditions — including reflux — without corresponding clinical data.

The human trial that is usually cited

The most frequently referenced human study of oral glutathione was a randomised controlled trial in healthy adults that examined whether supplementation raised body stores of glutathione. Researchers assigned participants to 250 mg per day or 1,000 mg per day of oral glutathione or placebo for six months and measured glutathione in blood compartments including erythrocytes, plasma, lymphocytes and buccal cells, reporting increases in body stores with supplementation (PMID 24791752). The study was designed around biochemical stores and oxidative-stress markers rather than any disease endpoint, and it did not enrol people with reflux or report gastrointestinal symptom outcomes.

That distinction matters for anyone reading about glutathione and heartburn. A trial can show that an oral dose changes a laboratory measurement without showing that the change alters how an organ behaves. No published work in this verified set connected the glutathione increases reported in that trial to oesophageal acid exposure, mucosal healing or symptom relief.

Animal and gut-focused models

Intestinal barrier work in piglets

The closest animal model to a digestive-tract question was a study in weaned piglets given diquat, a chemical used experimentally to provoke oxidative stress. Researchers reported that dietary glutathione supplementation attenuated oxidative stress markers and improved intestinal barrier measures in the diquat-treated animals (PMID 37133420). The barrier tissue studied was intestinal, not oesophageal, and the insult was a toxicant challenge rather than refluxed gastric contents, so the design does not model reflux injury.

Other species

In an aquaculture study, dietary reduced glutathione was reported to improve growth, antioxidant capacity and immune measures in Chinese mitten crab (PMID 32135343). In reproductive biology, adding reduced glutathione to a semen freezing extender was examined for effects on frozen-thawed bull semen and in vitro fertilisation outcomes (PMID 34866119). These are legitimate studies of glutathione's antioxidant role in their own fields and have no bearing on human oesophageal physiology.

Evidence map

Why measurement methods complicate the picture

Glutathione is chemically unstable outside controlled conditions, and the field has invested heavily in measuring it accurately. One group described quantitative real-time imaging of glutathione in living systems, an approach intended to capture dynamic intracellular concentrations rather than a single averaged extract value (PMID 28703127). Protocol literature also covers the measurement of glutathione reductase activity, the enzyme that regenerates reduced glutathione from its oxidised form (PMID 23045061).

Because different assays sample different compartments — whole blood, plasma, erythrocytes, buccal cells, tissue homogenates — two studies reporting "glutathione levels" may not be describing the same thing. In a hypothetical reflux trial, this would matter a great deal: oesophageal mucosal glutathione status is not the same measurement as circulating glutathione, and no verified study in this set measured the former in people with reflux.

Glutathione also appears in food chemistry

Glutathione is not only a supplement ingredient. Food scientists have studied it as a dough-active thiol, and one study examined the effect of glutathione on the taste and texture of type I sourdough bread (PMID 28502176). That work is included here only to illustrate how broadly the molecule appears in the literature; it says nothing about digestion, acid secretion or reflux symptoms.

Safety and tolerability: What Studies Report

Safety reporting in this set is limited and comes from outside the gastrointestinal field. A 2025 narrative review examined glutathione supplementation used for skin lightening and reported that the evidence base was heterogeneous and that safety and regulatory concerns had been raised, particularly around non-oral administration routes (PMID 40013212). The six-month randomised trial in healthy adults described supplementation at 250 mg and 1,000 mg daily and focused on glutathione stores and oxidative-stress markers rather than on a formal adverse-event framework (PMID 24791752).

No verified paper reported adverse events in people with reflux, in people taking acid-suppressing medication, or in anyone with oesophageal disease. Absence of reported harm in unrelated populations is not the same as demonstrated safety in a specific clinical group, and the reviews cited here make no such claim.

Limitations of the available evidence

• No condition-specific studies. Nothing in the verified set enrolled participants with acid reflux or measured reflux endpoints.
• Endpoint mismatch. The human trial measured glutathione stores, not symptoms or mucosal healing (PMID 24791752).
• Species and model gaps. The gut-barrier data came from piglets given a chemical oxidant challenge, a very different insult from refluxed acid and pepsin (PMID 37133420).
• Mechanistic distance. Reviews describing glutathione's antioxidant and enzymatic roles do not extend those roles to any clinical outcome (PMID 36707132, PMID 37804696).
• Heterogeneous measurement. Assay and compartment differences make cross-study comparison difficult (PMID 23045061, PMID 28703127).

Why oxidative stress keeps coming up in reflux discussions

Glutathione-dependent enzymes have been profiled in human tissue in other contexts; one study examined the relationship between glutathione-dependent enzymes and the immunohistochemical profile of glial neoplasms (PMID 36289655). Work of that kind shows that glutathione enzymes vary across tissues and disease states, which is one reason researchers have speculated about redox involvement in inflamed mucosa generally. Speculation is where that thread stops in this evidence set — no verified study measured glutathione enzymes in oesophageal tissue from people with reflux.

What a meaningful study would need

1. Participants with objectively confirmed reflux, for example by endoscopy or pH monitoring.
2. A defined, blinded comparison against placebo or standard care.
3. Pre-specified clinical endpoints such as validated symptom scores or mucosal healing, not only biochemical markers.
4. Measurement of glutathione in a relevant compartment, with an assay method described in enough detail to reproduce (PMID 23045061).
5. Systematic adverse-event capture, given how thin the safety reporting is outside dermatology contexts (PMID 40013212).

Until such work is published, statements linking glutathione to heartburn relief are extrapolations from general antioxidant biology rather than findings. Anyone comparing sources should check whether a cited paper actually enrolled people with reflux; in this verified set, none did.

References

• The antioxidant glutathione (Vitamins and Hormones, 2023)
• Randomized controlled trial of oral glutathione supplementation on body stores of glutathione (European Journal of Nutrition, 2015)
• Exploring the Safety and Efficacy of Glutathione Supplementation for Skin Lightening: A Narrative Review (Cureus, 2025)
• Quantitative real-time imaging of glutathione (Nature Communications, 2017)
• Effect of Glutathione on the Taste and Texture of Type I Sourdough Bread (Journal of Agricultural and Food Chemistry, 2017)
• Effects of reduced glutathione supplementation in semen freezing extender on frozen-thawed bull semen and in vitro fertilization (Journal of Reproduction and Development, 2022)
• The Glutathione Theory of Aging (Alternative Therapies in Health and Medicine, 2024)
• Measurement of glutathione reductase activity (Current Protocols in Toxicology, 2001)
• Glutathione and peroxisome redox homeostasis (Redox Biology, 2023)
• Dietary reduced glutathione supplementation can improve growth, antioxidant capacity, and immunity on Chinese mitten crab, Eriocheir sinensis (Fish & Shellfish Immunology, 2020)
• Relationship between Glutathione-Dependent Enzymes and the Immunohistochemical Profile of Glial Neoplasms (Biomedicines, 2022)
• Dietary glutathione supplementation attenuates oxidative stress and improves intestinal barrier in diquat-treated weaned piglets (Archives of Animal Nutrition, 2023)